Dighe Shashikant U, Khan Sajid, Soni Isha, Jain Preeti, Shukla Samriddhi, Yadav Rajeev, Sen Pratik, Meeran Syed M, Batra Sanjay
§Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India.
∥Academy of Scientific and Innovative Research, New Delhi 110025, India.
J Med Chem. 2015 Apr 23;58(8):3485-99. doi: 10.1021/acs.jmedchem.5b00016. Epub 2015 Apr 13.
A series of novel β-carboline-based N-heterocyclic carbenes was prepared via Mannich reaction between methyl 1-(dimethoxymethyl)-9H-pyrido[3,4-b]indole-3-carboxylate, formaldehyde, and primary amines. All compounds were evaluated for their antiproliferative activity using human breast cancer and lung cancer cell lines. Three compounds, 3c, 3j, and 3h, were discovered to display IC50 less than 10 μM against human breast cancer MDA-MB-231 cells at 24 h of treatment. Pharmacologically these compounds lead to G2/M phase cell cycle arrest and induction of cellular apoptosis by triggering intrinsic apoptotic pathway through depolarization of mitochondrial membrane potential and activation of caspases. At lower concentrations, these compounds also showed antimigratory and antiinvasive effects against highly metastatic human breast cancer MDA-MB-231 cells via aberration of MAP-kinase signaling and by the inhibition of matrix metalloproteinases. However, these analogues lack in vivo effect in mouse model which may be attributed to their strong affinity to HSA that was investigated spectroscopically with compound 3h.
通过1-(二甲氧基甲基)-9H-吡啶并[3,4-b]吲哚-3-羧酸甲酯、甲醛与伯胺之间的曼尼希反应,制备了一系列新型的基于β-咔啉的N-杂环卡宾。使用人乳腺癌和肺癌细胞系评估了所有化合物的抗增殖活性。发现三种化合物3c、3j和3h在处理24小时时对人乳腺癌MDA-MB-231细胞显示出小于10 μM的IC50。从药理学角度来看,这些化合物通过线粒体膜电位去极化和半胱天冬酶激活触发内源性凋亡途径,导致G2/M期细胞周期停滞并诱导细胞凋亡。在较低浓度下,这些化合物还通过MAP激酶信号转导异常和抑制基质金属蛋白酶,对高转移性人乳腺癌MDA-MB-231细胞表现出抗迁移和抗侵袭作用。然而,这些类似物在小鼠模型中缺乏体内效应,这可能归因于它们与HSA的强亲和力,已用化合物3h通过光谱法进行了研究。